March 3 Quick Takes: Megarounds for Akouos, Element; plus venture rounds by Kahr, Primmune, Lipidio and Scipio and more

Pivotal bioVentures, crossovers back Akouos in $105M series B
Akouos Inc., a gene therapy company developing treatments for hearing loss, raised $105 million in a series B round led by Pivotal bioVentures. New investors included Cormorant Asset Management, Cowen Healthcare Investments, EcoR1 Capital, Fidelity Management & Research Co., Polaris

Read the full 485 word article

How to gain access

Continue reading with a
two-week free trial.